{
    "code": "02016854",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02016854",
    "time": "2020-02-25 11:28:27",
    "許可證字號": "衛署藥輸字第016854號",
    "註銷狀態": "已註銷",
    "註銷日期": "78\/07\/25",
    "註銷理由": "移轉（申請商）",
    "製造許可登錄編號": "",
    "有效日期": "82\/09\/19",
    "發證日期": "77\/09\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201685406",
    "中文品名": "麻佳因腎上腺素注射液０．２５％",
    "英文品名": "MARCAINE ADRENALINE INJECTION 0.25%",
    "適應症": "局部性麻醉",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "EPINEPHRINE (ADRENALINEPIRENAMINE), BUPIVACAINE HCL (MONOHYDRATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "0402601100  中國化學製藥股份有限公司",
    "申請商地址": "台北巿襄陽路２３號",
    "主製造廠": [
        {
            "製造廠名稱": "FSE0022000  ASTRAZENECA AB",
            "製造廠廠址": "S-151 85 SODERTALJE  SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212000600",
            "成分名稱": "EPINEPHRINE (ADRENALINEPIRENAMINE)",
            "含量描述": "5.50",
            "含量": "5.5000000000",
            "單位": "U\/MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "7200008216",
            "成分名稱": "BUPIVACAINE HCL (MONOHYDRATE)",
            "含量描述": "2.50",
            "含量": "2.5000000000",
            "單位": "MG"
        }
    ]
}